Human exposure to microplastics and nanoplastics (MNPs) is an emerging concern with potential implications for health. As awareness of this issue grows, it has prompted increasing scientific attention toward understanding if, and how, MNPs accumulate in human tissues. In a recent study, Nihart et al. used the analytical technique of pyrolysis gas chromatography–mass spectrometry (Py-GC–MS) to detect MNPs in human liver, kidney and brain, reporting the highest concentrations in the brain, with polyethylene as the predominant polymer. The study as reported appears to face methodological challenges, such as limited contamination controls and lack of validation steps, which may affect the reliability of the reported concentrations. In this Matters Arising, we highlight methodological limitations that have general relevance for advancing robust and reproducible MNP detection in human biomonitoring studies.